In vivo longitudinal imaging of experimental human papillomavirus infection in mice with a multicolor fluorescence mini-endoscopy system

Cancer Prevention Research

Volumn 4, Issue 5, 2011, Pages 767-773

  Mitsunaga, Makoto ^a   Kosaka, Nobuyuki ^a   Kines, Rhonda C ^a   Roberts, Jeffrey N ^a   Lowy, Douglas R ^a   Schiller, John T ^a   Ishihara, Yasushige ^b   Hasegawa, Akira ^b   Choyke, Peter L ^a   Kobayashi, Hisataka ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b OLYMPUS CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERFERON; MEDROXYPROGESTERONE ACETATE; NONOXINOL 9; RECOMBINANT ALPHA2B INTERFERON; RED FLUORESCENT PROTEIN; WART VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CERVICOVAGINAL INFECTION; DISEASE COURSE; DRUG EFFICACY; ENDOSCOPY; EXPERIMENTAL MODEL; FEMALE; FEMALE GENITAL SYSTEM; FEMALE GENITAL TRACT INFECTION; FLUORESCENCE IMAGING; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOCOMPETENCE; MOUSE; MULTICOLOR ENDOSCOPIC FLUORESCENCE IMAGING SYSTEM; NONHUMAN; NUDE MOUSE; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; REPORTER GENE; TREATMENT OUTCOME; VIRUS CAPSID; VIRUS LIKE AGENT;

ANIMALS; ENDOSCOPY; FEMALE; FLUORESCENCE; GREEN FLUORESCENT PROTEINS; HUMANS; MICE; MICE, INBRED BALB C; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES;

EID: 79955816880     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-10-0334     Document Type: Article

References (20)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9. (Pubitemid 29406813)
2. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-78.
3. Siddiqui MA, Perry CM. Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil). Drugs 2006;66:1263-71; discussion 1272-3.
4. Bryan JT. Developing an HPV vaccine to prevent cervical cancer and genital warts. Vaccine 2007;25:3001-6. (Pubitemid 46482731)
5. Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, Choyke PL, et al. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 2007;13:857-61. (Pubitemid 47038188)
6. Buck CB, Pastrana DV, Lowy DR, Schiller JT. Efficient intracellular assembly of papillomaviral vectors. J Virol 2004;78:751-7. (Pubitemid 38067597)
7. Buck CB, Thompson CD, Pang YY, Lowy DR, Schiller JT. Maturation of papillomavirus capsids. J Virol 2005;79:2839-46. (Pubitemid 40270562)
8. Breitburd F, Kirnbauer R, Hubbert NL, Nonnenmacher B, Trin-Dinh-Desmarquet C, Orth G, et al. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol 1995;69:3959-63.
9. Suzich JA, Ghim SJ, Palmer-Hill FJ, White WI, Tamura JK, Bell JA, et al. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci U S A 1995;92:11553-7. (Pubitemid 26014152)
10. Caldeira JDoC, Medford A, Kines RC, Lino CA, Schiller JT, Chackerian B, et al. Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7. Vaccine 2010;28:4384-93.
11. Cuburu N, Kweon MN, Hervouet C, Cha HR, Pang YY, Holmgren J, et al. Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection. J Immunol 2009;183:7851-9.
12. Yang M, Baranov E, Moossa AR, Penman S, Hoffman RM. Visualizing gene expression by whole-body fluorescence imaging. Proc Natl Acad Sci U S A 2000;97:12278-82.
13. Zhao M, Yang M, Baranov E, Wang X, Penman S, Moossa AR, et al. Spatial-temporal imaging of bacterial infection and antibiotic response in intact animals. Proc Natl Acad Sci U S A 2001;98:9814-8. (Pubitemid 32769386)
14. Hoffman RM, Zhao M. Whole-body imaging of bacterial infection and antibiotic response. Nat Protoc 2006;1:2988-94.
15. Tran Cao HS, Kaushal S, Lee C, Snyder CS, Thompson KJ, Horgan S, et al. Fluorescence laparoscopy imaging of pancreatic tumor progression in an orthotopic mouse model. Surg Endosc 2011;25:48-54.
16. Hoffman RM, Yang M. Color-coded fluorescence imaging of tumor-host interactions. Nat Protoc 2006;1:928-35.
17. Hoffman RM. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 2005;5:796-806. (Pubitemid 41400779)
18. Johnson KM, Kines RC, Roberts JN, Lowy DR, Schiller JT, Day PM. Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol 2009;83:2067-74.
19. Kines RC, Thompson CD, Lowy DR, Schiller JT, Day PM. The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci U S A 2009;106:20458-63.
20. Keyaerts M, Verschueren J, Bos TJ, Tchouate-Gainkam LO, Peleman C, Breckpot K, et al. Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D-luciferin: effect on intensity, time kinetics and repeatability of photon emission. Eur J Nucl Med Mol Imaging 2008;35:999-1007.